Patient with myelodysplastic syndrome and acute myelocytic leukemia at Dr. Soetomo General Hospital,Surabaya

• Main Authors: Mulya Dinata, Pudji Rahayu, Siprianus Ugroseno Yudho Bintoro, Edi Widjajanto
• Format: Article PeerReviewed
• Language: English; English; English
• Published: Association of Pharmaceutical Innovators 2019
• Subjects: R Medicine (General); RC Internal medicine
• Online Access: http://repository.unair.ac.id/96213/1/Patient%20with%20myelodysplastic%20syndrome%20and%20acute%20myelocytic%20leukimia%20Dr%20Soetomo%20General%20Hospital%20Surabaya.pdf; http://repository.unair.ac.id/96213/2/Patient%20with%20myelodysplastic%20syndrome.pdf; http://repository.unair.ac.id/96213/3/Patient%20with%20myelodysplastic%20syndrome%20and%20acute%20myelocytic%20leukimia%20Dr%20Soetomo%20General%20Hospital%20Surabaya.pdf; http://repository.unair.ac.id/96213/; http://jprsolutions.info/files/final-file-5d9f2ab8014c94.35952500.pdf
• Institution: Universitas Airlangga

Background: According to the World Health Organization, there are 250 cases of leukemia globally. The case fatality rate (CFR) is at 76%, for young/middle age, the CFR is 35–40%, and for age older than 60, it is 5–15%. The occurrence of acute myelocytic leukemia (AML) is 3.5/100,000 people per yea...